Auto saved by Logseq

master
FMS 9 months ago
parent f0e0acb6db
commit d5ded03d34

@ -59,7 +59,7 @@
- Of particular interest where the ocular nosequé
- El clinical trial is under review. Nothing to highlight regarding safety, which lead us to go to test safety with bigger populations.
- consideramos lo de 3 dosis para situaciones que no son las de MDA sino otros escenarios.
- For strongi we didn't reach the recruitement size. The answe
- For strongi we didn't reach the recruitement size. The answer we wanted to provide we couldnt give.
-
- ## Cosas de gastos del [[Evento]]
- Sala, catering, técnicos (Caixaforum)

Loading…
Cancel
Save